ライフサイエンスコーパス: stroke scale

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します

1 n score on the National Institutes of Health Stroke Scale.

2 ilder strokes (National Institutes of Health Stroke Scale 0-4).

3 lation (median National Institutes of Health Stroke Scale 12, 13, and 9, respectively).

4 edian baseline National Institutes of Health Stroke Scale = 14 (interquartile range [IQR] = 11-20), a

5 (73+/-9 years, National Institute of Health Stroke Scale 2+/-2, mobile 10 metres with/without aid) w

6 d positive if the sum of the age and the NIH Stroke Scale (a 15-item neurological examination scale w

7 iated with the National Institutes of Health Stroke Scale+age score and 30-day mortality after ischem

8 ion and fatigue after correcting for the NIH Stroke Scale, age, benzodiazepine exposure, and time of

9 tly better than National Institute of Health Stroke Scale alone regarding prediction error (Wilcoxon

10 mpared with the National Institute of Health Stroke Scale alone.

11 duction in the National Institutes of Health Stroke Scale and a favorable odds ratio of a modified Ra

12 = 0.018) after correction for admission NIH Stroke Scale and age, and with worse QOL in the domains

13 n for baseline National Institutes of Health Stroke Scale and age, to treatment with desmoteplase (90

14 y means of the National Institutes of Health Stroke Scale and the modified Rankin Scale (mRS).

15 as measured by National Institutes of Health Stroke Scale) and computer tomography changes (as measur

16 e, admit National Institutes of Health (NIH) Stroke Scale, and any benzodiazepine exposure.

17 y to the score: National Institute of Health Stroke Scale at admission, hemineglect, female sex, atri

18 or more on the National Institutes of Health Stroke Scale between baseline and day 30 or a score of 0

19 gia screening, National Institutes of Health Stroke Scale documentation, early ambulation, fall risk

20 n pretreatment National Institutes of Health Stroke Scale documented in 87.7% of patients was 11 (int

21 P<0.0001, the National Institutes of Health Stroke Scale-documented cohort; 73.0% versus 64.0%, abso

22 roke severity (National Institutes of Health Stroke Scale), functional status (functional independenc

23 severe stroke (National Institutes of Health Stroke Scale >/=10) occurred in 8 (4%) and was strongly

24 haemic stroke (National Institutes of Health Stroke Scale >3) versus those with acute intracerebral h

25 Stroke Prognostication using Age and the NIH Stroke Scale index, created by combining age in years pl

26 e and baseline National Institutes of Health Stroke Scale, lack of recanalization, history of atrial

27 Baseline National Institutes of Health Stroke Scale (median, 15; interquartile range [IQR], 11-

28 as assessed by National Institutes of Health Stroke Scale (NIHSS [r = 0.225; p = 0.002]) and to advan

29 years of age, National Institutes of Health Stroke Scale (NIHSS) </=25, and selected only on the app

30 ured using the National Institutes of Health Stroke Scale (NIHSS) and stroke infarct size was measure

31 scores of the National Institutes of Health Stroke Scale (NIHSS) and Stroke-Specific Quality of Life

32 s 5 and 30; the National Institute of Health Stroke Scale (NIHSS) at baseline, 24 h, and at days 5 (o

33 qual to 75% on National Institutes of Health Stroke Scale (NIHSS) between baseline and 24 hours, was

34 severity, the National Institutes of Health Stroke Scale (NIHSS) is an important predictor of patien

35 Although National Institutes of Health Stroke Scale (NIHSS) is an important prognostic variable

36 er decrease in National Institutes of Health Stroke Scale (NIHSS) over 24 hours and 90-day modified R

37 lation, higher National Institutes of Health Stroke Scale (NIHSS) score (>10), and isolated/combined

38 stratified by National Institutes of Health Stroke Scale (NIHSS) score (severe stroke > or =14, less

39 ays, change in National Institutes of Health Stroke Scale (NIHSS) score at 24 hours, all-cause mortal

40 oke onset; the National Institutes of Health Stroke Scale (NIHSS) score measured at the time of scann

41 ith a baseline National Institutes of Health stroke scale (NIHSS) score of 6 or more who could be tre

42 c stroke and a National Institutes of Health Stroke Scale (NIHSS) score of 8-20 to treatment with int

43 e assessed the National Institutes of Health Stroke Scale (NIHSS) score serially and functional outco

44 le, and median National Institutes of Health Stroke Scale (NIHSS) score was 17 (interquartile range [

45 edian baseline National Institutes of Health Stroke Scale (NIHSS) score was 5 (interquartile range 2-

46 uring PSR, the National Institutes of Health Stroke Scale (NIHSS) score worsened by a mean (SD) 2.5 (

47 stment for age, National Institute of Health Stroke Scale (NIHSS) score, Alberta Stroke Program Early

48 se level (BGL), National Institute of Health Stroke Scale (NIHSS) score, and clinical parameters were

49 high baseline National Institutes of Health Stroke Scale (NIHSS) score, larger ICH, presence of intr

50 tion; (2) lower National Institute of Health stroke scale (NIHSS) score; (3) no hypertension history.

51 of treatment, National Institutes of Health Stroke Scale (NIHSS) scores of 5 or higher, and lesions

52 strokes and US National Institutes of Health Stroke Scale (NIHSS) scores of 8-29 within 8 h of sympto

53 racy of serial National Institutes of Health Stroke Scale (NIHSS) scores to detect complete early rec

54 (TCD) and the National Institutes of Health Stroke Scale (NIHSS) were used to monitor consecutive pa

55 clusion of the National Institutes of Health Stroke Scale (NIHSS), a measure of stroke severity not i

56 including the National Institutes of Health stroke scale (NIHSS), the modified Rankin scale (mRS), t

57 dex (BI) and the National Institute of Heath Stroke Scale (NIHSS).

58 cording to the National Institutes of Health Stroke Scale (NIHSS): the difference between the two gro

59 mented for the National Institutes of Health Stroke Scale (NIHSS, a 15-item neurological examination

60 ssessed on the National Institutes of Health Stroke Scale (NIHSS, a 42-point scale on which higher sc

61 easured by the National Institutes of Health Stroke Scale (NIHSS; range of 0-42, with a higher score

62 re included (mean age = 66 years, median NIH Stroke Scale [NIHSS] = 16, median time from symptom onse

63 le disability (National Institutes of Health Stroke Scale [NIHSS] score >/=6 and modified Rankin Scal

64 mm Hg; median National Institutes of Health stroke scale [NIHSS] score 9 [IQR 5-16] points) were ran

65 stment for the National Institutes of Health Stroke Scale [NIHSS] score [8-19, indicating moderately

66 ery at day 90 (National Institutes of Health Stroke Scale [NIHSS] score of < or =1); secondary end po

67 tients: median National Institutes of Health Stroke Scale [NIHSS] score, 11 [interquartile range, 5-1

68 st 4 points on National Institutes of Health Stroke Scale [NIHSS]); and fatal intracerebral haemorrha

69 nical deficit (National Institutes of Health stroke scale, NIHSS score range: 8-23) and CT Perfusion

70 omography scan, Age (>75 years = 1), and NIH Stroke Scale on admission (>/=10 = 1).

71 duction on the National Institutes of Health Stroke Scale or a score of 0 or 1 at day 3).

72 Initial National Institutes of Health Stroke Scale ranged from 1 to 38.

73 onal measures (National Institutes of Health Stroke Scale, Rankin Disability Scale, Barthel Activitie

74 =4.5 hours and National Institutes of Health Stroke Scale score >/=6.

75 troke included National Institutes of Health stroke scale score >0, prior stroke, prior transient isc

76 severe stroke (National Institutes of Health Stroke Scale score >25), onset-to-treatment time >4.5 ho

77 line severity (National Institutes of Health Stroke Scale score >6), early BBB disruption was found t

78 95% CI 6%-31%; National Institutes of Health Stroke Scale score >8: 27% decrease in DTN time, 95% CI

79 ute lesion volumes correlated with the acute stroke scale score (r = 0.56), the chronic stroke scale

80 e stroke scale score (r = 0.56), the chronic stroke scale score (r = 0.63), and chronic lesion volume

81 Chronic volumes correlated with the chronic stroke scale score (r = 0.86) and the Barthel index (r =

82 roke severity (National Institutes of Health Stroke Scale score 6-8: 19% decrease in DTN time, 95% CI

83 easured by the National Institutes of Health Stroke Scale Score and the Barthel index.

84 hange in National Institutes of Health (NIH) Stroke Scale score at 7 days after stroke.

85 e (r = -0.42), National Institutes of Health Stroke Scale score at admission (r = -0.27), and modifie

86 Median National Institutes of Health Stroke Scale score at admission was 13.5, 16.0, 15.5, 15

87 National Institutes of Health Stroke Scale score at onset (odds ratio per 1-point incr

88 Mean National Institutes of Health stroke scale score at presentation was 9.5 (SD 8.1) poin

89 or increase in National Institutes of Health Stroke Scale score by >or=2 points and hemorrhage growth

90 vement (median National Institutes of Health Stroke Scale score change: tenecteplase, 6; alteplase, 1

91 vement (median National Institutes of Health Stroke Scale score change: tenecteplase, 7; alteplase, 2

92 dian change in National Institutes of Health Stroke Scale score from baseline to 24 h, was greater in

93 improvement in National Institutes of Health Stroke Scale score of >or=8 points at 30 days or a modif

94 d TIA-S with a National Institutes of Health Stroke Scale score of 0 to 3 who presented to the emerge

95 s plus a National Institutes of Health (NIH) Stroke Scale score of 100 or higher (and hereafter refer

96 ars and median National Institutes of Health Stroke Scale score of 19 (interquartile range, 15-23).

97 (22.4%) had a National Institutes of Health Stroke Scale score of 5 or less and 5910 had complete da

98 and a baseline National Institutes of Health Stroke Scale score of 5 or less.

99 on, the median National Institutes of Health Stroke Scale score was 10 (interquartile range, 4-18).

100 rs, the median National Institutes of Health Stroke Scale score was 11.0 (interquartile range, 6-17),

101 d median entry National Institutes of Health Stroke Scale score was 13 (range, 6-25).

102 Median National Institutes of Health Stroke Scale score was 13 before harvest, 8 at 7 days, a

103 edian baseline National Institutes of Health Stroke Scale score was 13.

104 Median National Institutes of Health Stroke Scale score was 16 (IQR 13-21).

105 The median National Institutes of Health Stroke Scale score was 17 (range, 3-35) and the median o

106 age was 68.3 years and median admission NIH Stroke Scale score was 19.

107 The median National Institutes of Health Stroke Scale score was 21 (interquartile range [IQR], 15

108 The median National Institutes of Health Stroke Scale score was 3 (interquartile range, 0-9) and

109 edian baseline National Institutes of Health Stroke Scale score was 9 vs 9 vs 12 (P < .01).

110 ermined by the National Institutes of Health Stroke Scale score was not related to preventability of

111 2-weighted imaging (r = 0.90) to the chronic stroke scale score were higher.

112 sion, age, and National Institutes of Health Stroke Scale score were significant after multivariate a

113 roke severity (National Institutes of Health Stroke Scale score), site of occlusion (internal carotid

114 rsening on the National Institutes of Health Stroke Scale score).

115 olysis (median National Institutes of Health Stroke Scale score, 14; interquartile range, 9-17), 55%

116 edian baseline National Institutes of Health Stroke Scale score, 15 vs 17 [P = .03]; median diffusion

117 years; median National Institutes of Health Stroke Scale score, 5; mean baseline oxygen saturation,

118 evere baseline National Institutes of Health Stroke Scale score, absence of specific abnormalities (e

119 age, baseline National Institutes of Health Stroke Scale score, and glucose levels.

120 Age, sex, National Institutes of Health Stroke Scale score, and intubation did not affect delays

121 r the baseline National Institutes of Health Stroke Scale score, diffusion-weighted imaging Alberta S

122 luding age and National Institutes of Health Stroke Scale score, generated by an independent statisti

123 e race, higher National Institutes of Health Stroke Scale score, higher serum glucose, atrial fibrill

124 for admission National Institutes of Health Stroke Scale score, history of atrial fibrillation, prem

125 /=15) baseline National Institutes of Health Stroke Scale score, larger (>/=15 mL) ICH volume, greate

126 usted for age, National Institutes of Health Stroke Scale score, previous stroke, atrial fibrillation

127 age, baseline National Institutes of Health Stroke Scale score, sex, and baseline blood glucose conc

128 criteria (age, National Institutes of Health Stroke Scale score, time from onset, baseline modified R

129 with a higher National Institutes of Health Stroke Scale score.

130 ncrease in the National Institutes of Health Stroke Scale score.

131 nt for age and National Institutes of Health Stroke Scale score.

132 ated with worse National Institute of Health Stroke Scale scores at presentation.

133 graphic scans, National Institutes of Health Stroke Scale scores at those times, and proximal middle

134 d as change in National Institutes of Health Stroke Scale scores between the acute and 1-month assess

135 ealth (NIH) stroke scale scores, outcome NIH stroke scale scores, and final lesion volume.

136 hypertension, National Institutes of Health Stroke Scale scores, collateral status, and the use of m

137 initial National Institutes of Health (NIH) stroke scale scores, outcome NIH stroke scale scores, an

138 pressure, and National Institutes of Health Stroke Scale scores.

139 greater neurological improvement on the NIH Stroke Scale than high-dose aptiganel patients (mean imp

140 For each group, median NIH Stroke Scale was 12, median age was 72 years, and median

141 ld; the median National Institutes of Health Stroke Scale was 3 (interquartile range, 1-9).

142 The Modified National Institutes of Health Stroke Scale was used to identify neurologic abnormaliti

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。